Catena Biosciences

Bringing People and Proteins Together

Our mission is to advance revolutionary protein coupling technology to create new therapies for cancer, vaccines, and to retrain the immune system to cure autoimmune disorders

Meet The Team

Our team is made up of bright and like-minded individuals, who have come together to explore endless possibilities in creating new treatments utilizing our protein conjugation technology. We come from a variety of different fields and technical backgrounds, yet our passion for Catena Biosciences's mission ties us all together. Check out the people who make Catena Biosciences the amazing company it truly is!

Marco Lobba
Co-Founder & CEO

Geo Guillen
Co-Founder & COO

Matt Francis
Co-Founder & Chief Science Advisor

Originating from the Berkeley Labs

Our Science is Supported by the Top Minds at UC Berkeley

Professor Matthew Francis

Chair of the UC Berkeley Department of Chemistry, Professor Francis has spent the past two decades as the world's leading expert in protein modification chemistry.
He has been involved in numerous startups coming from his lab and has been a faculty member at UC Berkeley since 2001.

The Francis Lab

Professor Jennifer Doudna

2020 Nobel Prize Laureate - Chemistry
Director of the Innovative Genomics institute, Professor Doudna is best known for the discovery of the CRISPR gene editing platform. Her biography contains innumerable awards and accolades for her pioneering work in gene editing and RNA biology.
She has overseen the launch of many successful startups and has been a faculty member in UC Berkeley's Department of Molecular and Cell Biology since 2002.

The Doudna Lab

Our Technology

We are a team of talented scientists and entrepreneurs originating in the Berkeley Labs. In our research, we uncovered a novel protein conjugation method that can bring breakthroughs in biological therapeutics, autoimmune disorders, and vaccine development.

Catena’s technology allows the attachment of any two proteins together faster and more selectively than any competing method by attaching the natural amino acids tyrosine and cysteine. Since our platform uses only naturally occurring amino acids it is more widely applicable than competing technologies and can be used to create complicated constructs far beyond the capability of genetic fusions or chemical attachment found in the industry today!